The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.
A new discovery from researchers at The University of Texas at Austin and The University of Texas MD Anderson Cancer Center helps explain why some ...
Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations ...
Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though ...
Stories by SWNS on MSN
Brit first in Europe to receive new drug that 'attaches' to cancer cells
A Brit has become the first patient in Europe to trial a pioneering antibody drug that ‘attaches’ to cancer cells. Brian ...
The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates (ADCs), a class of treatments that are designed to deliver potent che ...
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...
AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...
Weight-loss injections like Ozempic may help cancer patients with brain tumours live longer. But experts urge caution before ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
Preclinical evidence supports azenosertib ADC combinations as potential promising therapeutic strategies for Triple-Negative Breast Cancer ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced three of the Company’s internally-developed investigational oncology therapies will be presented across four poster sessions at the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results